Human Induced Pluripotent Stem Cell-Derived Macrophages Ameliorate Liver Fibrosis
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
With an increasing number of patients with degenerative hepatic diseases, such as liver fibrosis, and a limited supply of donor organs, there is an unmet need for therapies that can repair or regenerate damaged liver tissue. Treatment with macrophages that are capable of phagocytosis and anti-inflammatory activities such as secretion of matrix metalloproteinases (MMPs) provide an attractive cellular therapy approach. Human induced pluripotent stem cells (iPSCs) are capable of efficiently generating a large-scale, homogenous population of human macrophages using fully defined feeder- and serum-free differentiation protocol. Human iPSC-macrophages exhibit classical surface cell markers and phagocytic activity similar to peripheral blood-derived macrophages. Moreover, gene and cytokine expression analysis reveal that these macrophages can be efficiently polarized to pro-inflammatory M1 or anti-inflammatory M2 phenotypes in presence of LPS + IFN-γ and IL-4 + IL-13, respectively. M1 macrophages express high level of CD80, TNF-α, and IL-6 while M2 macrophages show elevated expression of CD206, CCL17, and CCL22. Here, we demonstrate that treatment of liver fibrosis with both human iPSC-derived macrophage populations and especially M2 subtype significantly reduces fibrogenic gene expression and disease associated histological markers including Sirius Red, αSMA and desmin in immunodeficient Rag2−/−γc−/− mice model, making this approach a promising cell-based avenue to ameliorate fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649 · cited 1×
“While classically activated M1 macrophages are known to drive inflammation and activation of hepatic stellate cells (HSCs) and myofibroblasts, M2 macrophages are able to alleviate inflammation and stimulate regeneration in the injured liver (14).”
BackgroundMyofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805
Self-citationDivergent angiocrine signals from vascular niche balance liver regeneration and fibrosis
Ding, B.-S., Cao, Z., Lis, R., Nolan, D. J., Guo, P., Simons, M., Penfold, M. E., Shido, K., Rabbany, S. Y., & Rafii, S. (2014) · Nature · doi:10.1038/nature12681 · Cited by 626 · cited 4×
“They reported that BM-M1 exhibit anti-fibrotic activity via recruitment of endogenous macrophages expressing MMP-2, 9, 13, increasing collagen degradation and hepatic growth factor (HGF) secretion, and inducing hepatocyte proliferation.”
BackgroundInfluentialHaenseler, W., Sansom, S. N., Buchrieser, J., Newey, S. E., Moore, C. S., Nicholls, F. J., Chintawar, S., Schnell, C., Antel, J. P., Allen, N. D., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.017 · Cited by 593
Wilgenburg, B. V., Browne, C., Vowles, J., & Cowley, S. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071098 · Cited by 353
Thomas, J. A., Pope, C., Wojtacha, D., Robson, A. J., Gordon-Walker, T. T., Hartland, S., Ramachandran, P., Van Deemter, M., Hume, D. A., Iredale, J. P., et al. (2011) · Hepatology · doi:10.1002/hep.24315 · Cited by 346 · cited 3×
“These studies demonstrate clinically relevant improvement of liver fibrosis upon macrophage treatment (4).”
BackgroundMa, P.-F., Gao, C.-C., Yi, J., Zhao, J.-L., Liang, S.-Q., Zhao, Y., Ye, Y.-C., Bai, J., Zheng, Q.-J., Dou, K.-F., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.022 · Cited by 284 · cited 3×
“Ma et al(27) report on the therapeutic potential of M1 polarized BMDMs to ameliorate fibrosis via the recruitment of endogenous macrophages and NK cells that promote HSC apoptosis through MMPs and TRAIL.(27) While Rag2 / γc / mice lack NK cells, iPSC-M1 cells can potentially recruit MMP secreting-endogenous macrophage…”
BackgroundResultInfluentialInduced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer
Hermanson, D. L., Bendzick, L., Pribyl, L., McCullar, V., Vogel, R. I., Miller, J. S., Geller, M. A., & Kaufman, D. S. (2016) · Stem Cells · doi:10.1002/stem.2230 · Cited by 242 · cited 1×
“Human iPSCs derived from umbilical cord blood CD34 + cells (15,46-48) were maintained as undifferentiated cells on matrigel-6 coated tissue culture flasks in mTeSR media (STEMCELL Technologies).”
MethodSelf-citationMerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure
Triantafyllou, E., Pop, O. T., Possamai, L. A., Wilhelm, A., Liaskou, E., Singanayagam, A., Bernsmeier, C., Khamri, W., Petts, G., Dargue, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313615 · Cited by 226 · cited 1×
“Our human iPSC-M2 macrophages expressed high levels of surface receptors MerTK, CD36, TREM-2 which have previously reported to promote tissue repair (39-41), as well as genes that are involved in tissue regeneration such as Gpnmb (21) and SDC-1 (22,23).”
BackgroundBuchrieser, J., James, W., & Moore, M. D. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.12.020 · Cited by 215 · cited 2×
“Indeed, unlike human PB-monocytes which arise from hematopoietic stem cells, human iPSC-MPro originate from yolk sac hematopoietic progenitor cells, self-renew during adult life through a Myb-independent proliferation mechanism and are more similar to tissue resident macrophages (12,24).”
BackgroundResult
Cited by
Engineered cellular immunotherapies in cancer and beyond
Finck, A. V., Blanchard, T., Roselle, C. P., Golinelli, G., & June, C. H. (2022) · Nature Medicine · doi:10.1038/s41591-022-01765-8 · Cited by 269
A new era of macrophage-based cell therapy
Na, Y. R., Kim, S. W., & Seok, S. H. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01068-z · Cited by 129
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial
Brennan, P. N., MacMillan, M., Manship, T., Moroni, F., Glover, A., Troland, D., MacPherson, I., Graham, C., Aird, R., Semple, S. I. K., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03406-8 · Cited by 66
Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation
Tadokoro, T., Murata, S., Kato, M., Ueno, Y., Tsuchida, T., Okumura, A., Kuse, Y., Konno, T., Uchida, Y., Yamakawa, Y., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg0338 · Cited by 58
TNC‑targeted CAR‑macrophage therapy alleviates liver fibrosis in mice
Chen, K., Lin, Z., Chen, L., Zhou, Y., Zhang, W., Wan, H., Huo, Y., Fu, Q., Gao, Z., Cheng, H., et al. (2025) · Military Medical Research · doi:10.1186/s40779-025-00667-3 · Cited by 11
“Previous studies have suggested that M1-polarized macrophages exert a profibrogenic effect on the liver and that liver fibrosis can be ameliorated by induced pluripotent stem cell-derived macrophage populations, especially those of the M2 subtype [33–35].”
Metadata
- Authors
- Pouyanfard, S., Meshgin, N., Cruz, L. S., Diggle, K., Hashemi, H., Pham, T. V., Fierro, M., Tamayo, P., Fanjul, A., Kisseleva, T., & Kaufman, D. S.
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-10-01
- Volume
- 39
- Issue
- 12
- Pages
- 1701-1717
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W3197815032
- Cited by
- 59
- References
- 18
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human Induced Pluripotent Stem Cell-Derived Macrophages Ameliorate Liver Fibrosis. https://app.cochat.ai/papers/10.1002/stem.3449
- The paper
- Pouyanfard, S., Meshgin, N., Cruz, L. S., Diggle, K., Hashemi, H., Pham, T. V., Fierro, M., Tamayo, P., Fanjul, A., Kisseleva, T., & Kaufman, D. S. (2021). Human Induced Pluripotent Stem Cell-Derived Macrophages Ameliorate Liver Fibrosis. Stem Cells. https://doi.org/10.1002/stem.3449
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.